Johnson & Johnson
Johnson & Johnson Hit With More Than $1 Billion Verdict on Hip Implants
The hip implants were defectively designed and the company failed to warn consumers about the risks.
J&J to Buy Hair Care Products Maker Vogue for $3.3 Billion
The transaction, slated to close in the third quarter, is not expected to have an impact on the company's 2016 sales or earnings forecasts.
Johnson & Johnson Ordered to Pay $55 Million in Talc-Powder Trial
The company had lost a previous trial and faces approximately 1,200 lawsuits accusing it of not adequately warning consumers about its talc-based products' cancer risks.
The Verdict Against Johnson & Johnson Doesn't Mean More Judgements Will Follow
While Jacqueline Fox's family won $72 million in damages this week, not all plaintiffs in the 1,200 similar pending talc powder-cancer cases will be cashing in.
Johnson & Johnson to Cut 3,000 jobs in Medical Devices Division
The company said the restructuring would affect its orthopaedics, surgery and cardiovascular businesses within the larger medical devices unit.